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ABSTRACT 
Objective: This study represents head and neck cancer patient’s care at Departement of Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) in 
Hasan Sadikin General Hospital during COVID-19 pandemic. 
Methods: The study is done using a retrospective descriptive method based on medical record data in patients with head and neck cancer at 
Oncology Departement of ORL-HNS, Hasan Sadikin General Hospital, Bandung from March to July 2020. Samples were selected with total sampling. 
All existing subjects who met the study criteria were enrolled. The inclusion criteria in this study were head and neck cancer patients from March to 
July 2020. The exclusion criteria were incomplete medical records data. 
Results: The number of outpatient visits at ORL-HNS Departement, Dr. Hasan Sadikin General Hospital Bandung from March to July was 3723 
patients with 1796 of them are oncology outpatients. There was a significant decrease in the number of ORL-HNS outpatient in April and May and 
began to increase steadily in June and July. This is in line with the start of the big-scale social restriction at the end of March and the start of the ‘new 
normal’ era in early June.  
Conclusion: The study demonstrates the significant impact of the COVID-19 crisis on oncological care. During COVID-19 pandemic, the treatment of 
HNC patients has been severely disrupted and caused a decrease in the number of procedures at Dr. Hasan Sadikin General Hospital Bandung. 
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INTRODUCTION 
The world at this time was affected by the novel Coronavirus disease 
(COVID-19) that first started in the city of Wuhan, Hubei province, 
China. The World Health Organization (WHO) facilitates the 
worldwide effort to deal with the effects and it declared COVID-19 as 
a global pandemic on March 11, 2020 [1]. At the point when the 
novel Covid SARS-CoV2 hit China most seriously during the long 
periods of December 2019–February 2020. Indonesia reported no 
case of infection at all. On March 2, 2020, the government announced 
two confirmed cases of COVID-19. As of September 25, 2020, the 
country has reached 262.022 confirmed cases, 4823 new cases, with 
10105 number of deaths, and 4343 number of recoveries with 
overall positive rate is 14,34% [1, 2]. 
After the initial and subsequent reports of infections, Indonesia started 
to realize the direness of the situation, and issued various policies and 
actions to overcome COVID-19, including appointing 100 domestic 
general hospitals as Referral Hospitals on March 3, 2020. To cope with 
the ever-increasing number of COVID-19 patients, the number of 
Referral Hospitals was increased to 227 on March 18, 2020. In the end 
of March 2020, the government finally decided to implement Large-
Scale Social Restriction in cities and provinces [1]. 
The COVID-19 pandemic prompted consequences for treatments, 
hospital visits, and healthcare systems, as underscored by the 
current examination, modifications in non-COVID-19 clinical 
consideration can't be avoided. Study investigating perspectives of 
cancer patients during the COVID-19 pandemic shows many patients 
were concerned about the consequences of the COVID-19 pandemic 
for their treatment or follow-up. In total, 47% of respondents were 
very concerned to be infected with SARSCoV-2 [1, 3]. Owing to the 
high infectivity and alarming increase in the number of cases 
affected by this contagious disease, most hospitals have decreased or 
all together stopped elective interventions in patients with HNC. 
Ambulatory visits have been curtailed, wards and operating rooms 
are emptied for emergency services, and ventilators are being 
prepared for COVID-19 patients [4]. 
Otorhinolaryngologists have an increased risk of COVID-19 
transmission due to the high concentration of virus particles in the 
nasal cavity, nasopharynx, oral cavity and oropharynx. During the 
early onset of the pandemic, many complaints about the availability of 
Personal Protective Equipment (PPE) for healthcare workers and PPE 
was extremely rare and expensive due to high demand. Besides 
limiting the capacity of medical care, the COVID-19 pandemic has 
explicit effect on oncological consideration. First, patients with an 
(active) malignancy may have an expanded danger of COVID-19. 
Second, malignancy may be an independent risk factor of a more 
severe course of COVID-19. Third, systemic anti-cancer treatment, 
such as chemotherapy, may increase the risk of a severe infection. 
Fourth, hospital visits that are required for many cancer treatments, 
may put cancer patients at risk to be infected with SARS-CoV-2 [3]. 
This study was intended to see the impact of the COVID-19 crisis on 
oncological care at the Department of Otorhinolaryngology-Head and 
Neck Surgery, Hasan Sadikin General Hospital Bandung Indonesia. 
MATERIALS AND METHODS 
This study was carried out from March to July 2020 at the 
Department of Otorhinolaryngology-Head and Neck, Dr. Hasan 
Sadikin General Hospital Bandung used the retrospective method. 
The population was all the head neck cancer patients who were 
hospitalized or received outpatient treatment. Medical records from 
study subjects were served as the secondary data. Samples were 
selected with total sampling. All existing subjects who met the study 
criteria were enrolled. The inclusion criteria in this study were head 
and neck cancer patients from March to July 2020. The exclusion 
criteria were incomplete medical records data. The study was 
approved by the Research Ethics Committee of the Faculty Medicine 
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Universitas Padjadjaran/Dr. Hasan Sadikin Hospital Bandung, 
Indonesia with ethical number 318/UN6. KEP/EC/2021. The data 
were derived with descriptive statistics, using frequency and 
percentage calculations by the Excel software. The results of the 
study were illustrated figures. 
RESULTS 
The number of outpatient visits at Otorhinolaryngology-Head and 
Neck Surgery Departement, Dr. Hasan Sadikin General Hospital 
Bandung from March to July was 3.723 patients with 1.796 of them 
are oncology outpatients. There was a significant decrease in the 
number of ORL-HNS outpatient in April and May and began to 
increase steadily in June and July. When compared with the number 
of ORL-HNS outpatient in February, there was a decrease of 72% of 
outpatients in April and reached 78% in May. Likewise, for ORL-HNS 
oncology patients, there was a decrease in outpatients by 58% in 
April and 66% in May compared to February. The number of 
outpatients started to increase in June with the addition of 
outpatients by more than 100% in ORL-HNS Outpatient and 43% in 
ORL-HNS oncology outpatient (fig. 1). 
  
 
Fig. 1: Comparison of outpatient’s number per month from March to July 
 
 
Fig. 2: Outpatient procedure 
 
 
Fig. 3: Inpatient procedure 
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The predominant of head and neck clinical diagnoses were 
nasopharyngeal carcinoma (53,88%), followed by sinonasal (15,1%) 
and larynx (12,8%). The majority of histological findings found in 
this study were undifferentiated carcinoma with 126 patients 
(48,84%), followed by squamous cell carcinoma with 66 patients 
(25,58%). The findings of patients with advanced head and neck 
tumors were higher than those in the early stages. There were 129 
patients (50 %) at stage IV, and 73 patients (28,29%) at stage III  
The most common procedure performed in outpatient clinics is rigid 
endoscopy with a total of 151 procedures (54%), followed by local 
biopsy with 46 procedures (16%) (fig. 2). 
Besides, the most common procedure performed in inpatient rooms 
is biopsy with a total of 11 procedures, followed by maxillectomy 
and tracheostomy with 3 procedures each (fig. 3). 
DISCUSSION 
The pandemic has carried new challenges to public health in various 
nations. However, COVID-19 which caused by a strain of coronavirus 
(SARS-CoV2), revealed our lack of preparedness given its 
unexpected and fast spread that caught many governments around 
the world unprepared. Indonesia is the fourth most populous 
country in the world, and thus is predicted to suffer greatly and over 
a longer time period when compared to other less-populous 
countries.[1]
The number of outpatient visits at Otorhinolaryngology-Head and 
Neck Surgery Department, Hasan Sadikin General Hospital 
Bandung from March to July was 3.723 patients with 1.796 of them 
are oncology outpatients. There was a significant decrease in the 
number of the ORL-HNS outpatient in April and May and began to 
increase steadily in June and July. This is in line with the start of 
the big-scale social restriction at the end of March and the start of 
the ‘new normal’ era in early June. Many patients were concerned 
about the consequences of the COVID-19 pandemic for their cancer 
treatment or follow-up. Study from Jodee et al. about the impact of 
the COVID-19 pandemic on cancer treatment based on the 
patient’s perspective shows that 47% of patients were very 
concerned to be infected with SARS-CoV-2. Patients who were 
under treatment were more often concerned to be infected than 
patients in follow-up and patients with incurable disease were also 
more often concerned than patients with curable or cured 
disease.
The degree of COVID-19 spread is currently around 
5.3%, which could theoretically rise if precautionary steps are not 
taken into account. Consequently, global avoidance of the 
dissemination of COVID-19 is a critical and immediate priority [10]. 
Most recent Coronavirus (COVID 19) Situation in Indonesia announced 
by WHO shows as of 23 September, 59.6% of affirmed cases were in 
Java: DKI Jakarta East Java, Central Java and West Java are the four top 
province as far as the number of affirmed cases. As revealed by the 
government on 23 September, the quantity of individuals testing for 
COVID-19 with polymerase chain response (PCR) was 25.498 and the 
combined number of individuals testing was 1.799.563. As of the same 
day, the proportion of people that recovered among the total 
confirmed COVID-19 cases was 73.0% [5].  
[5]
COVID-19 cases in Indonesia continue to increase rapidly. February 
4, Health Ministry declared Novel 2019-nCov as a disease that 
outlines potential transform of COVID-19 into an outbreak and what 
can be done. A specific emergency situation of COVID-19 declared by 
head of BNPB on 28 February 2020. President of Indonesia issued 
one decree and two fundamental regulations on the last day of 
March 2020. These regulations include: First, Regulation on National 
budgeting policy and the stability of budgeting system for COVID-19 
pandemic disaster and/or Managing threats for the national 
economy and/or the stabilization of budgeting system; Second, A 
declaration of community health emergency situation for COVID-19; 
Third, Big scale social restriction for accelerating COVID-19 
eradication [
 The decrease in the number of patients was also caused 
by Hasan Sadikin General Hospital as a one of the reference 
hospital for COVID-19 cases and limiting the number of non-
emergency patients for treatment. 
1].  
Globally, around 14% of COVID-19 cases reported to WHO are among 
health workers, and in some countries, this number rises to as much as 
35%. As of 12 September, 115 doctors have died from COVID-19, 
according to the Indonesian Doctors Association. To provide safe care for 
patients, health workers need a safe environment and adequate 
resources. One of the key strategies to keeping patients safe is keeping 
health workers safe.[5]Healthcare workers have emerged as a 
vulnerable population group during COVID-19 and securing supply 
chains of personal PPE has been identified as a critical issue to protect 
healthcare workers and to prevent health system overwhelm. During the 
early onset of COVID-19 pandemic, The Indonesian Doctors Association 
receives many complaints about the availability of PPE for healthcare 
workers and PPE was extremely rare and expensive due to high demand. 
In June 2020 the Trade Ministry has revoked the temporary ban on 
exporting PPE and its raw materials to provide enough supply and meet 
domestic needs [8]. 
Practically after 3 mo of passing the emergency response period and 
the big scale of social restriction, the Indonesian government has 
begun exploring the implementation of a new normal life and 
loosening the big scale of social restriction. This policy is in line with 
the continuous improvement of facilities in health services, including 
regulations on the prevention of virus transmission and an adequate 
supply of PPE.  
Otorhinolaryngologists have an increased risk of COVID-19 
transmission due to the high concentration of virus particles in the 
nasal cavity, nasopharynx, oral cavity and oropharynx. This is 
reinforced by the number of certain procedures and actions that 
cause Aerosol Generating Procedures (AGP) which are more difficult 
to prevent than droplets. The Indonesian Otorhinolaryngology-Head 
and Neck Surgery Association formulates guidelines for Adaptation 
of New Habits in ORL-HNS Services in the Era of the COVID-19 
Pandemic. The guideline includes recommendation of PPE that 
complies with standards, especially when carrying out examinations 
or actions that cause aerosols in the form of actions related to the 
airway, patient services in outpatient clinics, emergency 
departments, and inpatients, and in the operating room by providing 
the main points of consideration before restarting elective operative 
services and considering the use of telemedicine for patients who do 
not require a physical examination [7]. 
The most common procedures performed in outpatient clinics are 
rigid nasoendoscopy (151) and local biopsy (46), while inpatient 
procedures are biopsy (11) and maxillectomy (3). During the COVID-
19 pandemic, the procedures carried out were much less than 
before. Endoscopy are not considered AGP, but these procedures 
have the potential to increase the likelihood of coughing, choking, 
and sneezing, which in turn cause aerosolization, so it should be 
considered to prevent this aerosolization based on the clinical 
setting of the individual patient. The use of PPE is very important in 
keeping medical personnel and staff safe from transmission of 
COVID-19. The specific type of PPE used depends on the procedure. 
This is intended to reduce contact between patients and health 
workers at the hospital to prevent the spread of COVID-19. Personal 
protective equipment (PPE) in accordance with the standards is 
needed by an ENT surgeon, especially when carrying out examinations 
or actions that cause aerosols in the form of actions related to the 
airway. The type of PPE that is used when examine outpatient services 
is PPE level 2 which consists of head cap, google, face shields, N-95 
masks, waterproof gowns, gloves, and shoe covers. Meanwhile, the 
type of PPE used when performing surgery is PPE level 3 consisting of 
a coverall suit, head cap, google, face shield, N-95 mask, surgical mask, 
waterproof gown, double-layer gloves and boots. All patients 
undergoing surgery must be screened for COVID-19 [6, 7]. 
With the routine outpatient department (OPD) services being suspended 
to keep a check on social distancing, the government in most of the 
countries directed to start teleconsultations for the patients. The 
telemedicine approach clearly encourage us to reach more to 
communities with ENT screening. Being a specialty of high risk of 
exposure, telemedicine can be used for screening and triage of patients 
not only in COVID-19 times but also even after this phase and the 
services can be provided to inaccessible or difficult to reach patient [11]. 
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CONCLUSION 
COVID-19 pandemic has presented an unprecedented situation in 
human history, with massive disruption of health care activities. The 
treatment of HNC patients has been severely disrupted, with increased 
waiting times. Patients need to be directed to alternative treatment 
facilities, separate from a COVID-19 facility. Preoperative screening for 
COVID-19, availability of personal protective equipment, and isolation of 
suspected patients will act as confidence builders for health care teams 
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